StageBio, a leading provider of histology, pathology, image analysis, specimen archiving and biorepository services, is pleased to announce a strategic partnership with Pathcore, an innovative digital and computational pathology solutions provider. This collaboration marks a significant milestone in the advancement of pathology solutions, offering enhanced digital workflows, and improved efficiency for clients worldwide.
Products such as cytotoxic chemotherapeutics and AAV-based gene therapies are associated with gangliotoxicity. Despite this, prior toxicology guidance provided no recommendations for which sensory and autonomic ganglia to evaluate in nonclinical general toxicity studies.
Date: Sept. 26-29, 2023
Location: Basel, Switzerland
We're attending - connect with our team!
Date: Oct. 24-27, 2023
Location: Brussels, Belgium
Stop by our Booth #52 and connect with our team!
Date: Oct. 28-31, 2023
Location: Chicago, Illinois
StageBio is pleased to announce the opening of our latest facility in Marlborough, MA. Learn how we can help you address all your histopathology needs.
Established by the merger of industry leaders, StageBio is an integrated partner serving the full spectrum of your histopathology needs. Our experienced team of laboratory staff, board-certified pathologists and archiving specialists are both experts in their respective fields and stewards of your projects’ success.
StageBio expands its capabilities on both sides of the Atlantic with the acquisition of TPL Path Labs.